ORIC 10-Q: SEC filing

ORIC Pharmaceuticals

Filed with the SEC on · accession 0001193125-26-463577

ORIC filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. ORIC Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, cash position, and operating expenses. The stock moved -4.3% by the first close after the filing.

Summary of the filing

ORIC Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, cash position, and operating expenses. The filing contains no material corporate events such as executive changes, acquisitions, or regulatory actions.

Key details

FilerOric Pharmaceuticals, Inc.
Acquisition target (historical, 2020)Voronoi Inc.
Private placement investor (historical, 2020)Mirati Therapeutics, Inc.
Executive (likely ceo)Jacob Chacko

How ORIC stock reacted

Close before

$7.86

Nov 13, 2026

First close after

-4.33%

$7.52

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ORIC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ORIC?

Click here

Frequently asked questions

What did ORIC file with the SEC on Nov 16, 2026?

ORIC filed a 10-Q (SEC filing). ORIC Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, cash position, and operating expenses. The filing contains no material corporate events such as executive changes, acquisitions, or regulatory actions.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ORIC stock react to this filing?

ORIC closed at $7.86 before the filing and $7.52 on Nov 16, 2026 (-4.33%).

Other ORIC SEC filings

Get alerts when ORIC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days